Comorbidities and Vaccination Status of COVID-19 All-Cause Mortality at a Tertiary Care Center of Western IndiaPreventive Medicine Published on 2022-01-302022-10-31 Journal: Cureus [Category] COVID-19, [키워드] all-cause mortality Autoimmune disorders Breakthrough infection cardiovascular Care center comorbid patients Comorbidities Comorbidity conducted Corona Covaxin Coverage COVID COVID-19 COVID-19 vaccine Covishield death deaths defined diabetes disease disease onset doses Efficacy first dose higher risk HIV hypertension include India less morbidity and mortality Mortality Neurological disorders occurred Other Patient positive COVID-19 Prevent proportion renal RT-PCR second dose severe disease shown smoking status Tertiary vaccinated individuals vaccination Vaccine [DOI] 10.7759/cureus.21721 PMC 바로가기 [Article Type] Preventive Medicine
Awareness and Satisfaction About COVAXIN Vaccination Services at an Immunization Clinic in Nagpur: A Cross-Sectional StudyPreventive Medicine Published on 2022-01-062022-10-31 Journal: Cureus [Category] COVID-19, [키워드] adverse effect age analyzed applied Awareness carried chi-square test clinic college Comorbidity conducted coronavirus disease Covaxin COVID-19 COVID-19 vaccination COVID-19 vaccine cross-sectional Elderly population Epi Gender immunization India individual Initially interview knowledge majority material no difference participated provided question questionnaire receiving Result Satisfaction service social media subject subjects the vaccine vaccination [DOI] 10.7759/cureus.20983 PMC 바로가기 [Article Type] Preventive Medicine
Clinico-Epidemiological Profile of Breakthrough COVID-19 Infection among Vaccinated Beneficiaries from a COVID-19 Vaccination Centre in Bihar, IndiaOriginal Article Published on 2022-01-012022-10-31 Journal: Ethiopian Journal of Health Sciences [Category] COVID-19, SARS, [키워드] adopted Asymptomatic beneficiary Breakthrough COVID infections Breakthrough infection breakthrough infections carried categories conducted Covaxin COVID COVID-19 COVID-19 infection COVID-19 pandemic cross-sectional death diagnosed independent India individual Infection infections information majority male occurred participant Patna predictor profile proportion Randomly reported Result risk SARS CoV-2 second wave selected vaccinated individual vaccination [DOI] 10.4314/ejhs.v32i1.3 PMC 바로가기 [Article Type] Original Article
Immunogenicity and safety of a heterologous prime-boost COVID-19 vaccine schedule: ChAdOx1 vaccine Covishield followed by BBV152 CovaxinArticle Published on 2021-12-292023-06-19 Journal: Journal of Travel Medicine [Category] Fulltext, SARS, [키워드] Covaxin Covishield Heterologous regime immunogenecity SARS-CoV-2 [DOI] 10.1093/jtm/taab166 PMC 바로가기
Prime-Boost Vaccination With Covaxin/BBV152 Induces Heightened Systemic Cytokine and Chemokine ResponsesImmunology Published on 2021-10-152022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, SARS, [키워드] Activation Adaptive immune response baseline CCL4 chemokine chemokines Covaxin COVID-19 CX3CL1 CXCL1 CXCL10 CXCL2 cytokine Cytokines GM-CSF healthy volunteers IFNs IFNγ IL-10 IL-12 IL-13 IL-17A IL-1α IL-1β IL-2 IL-33 IL-4 IL-5 IL-6 IL-7 inactivated induce investigated plasma pro-inflammatory cytokine recipients response robust SARS-CoV-2 SARS-CoV-2 vaccine systemic systemic immune response TNFα Type vaccination Vaccine virion [DOI] 10.3389/fimmu.2021.752397 PMC 바로가기 [Article Type] Immunology
Neutralization of VUI B.1.1.28 P2 variant with sera of COVID-19 recovered cases and recipients of Covaxin an inactivated COVID-19 vaccineCOVID-19 회복 사례 및 비활성화된 COVID-19 백신인 Covaxin의 수혜자의 혈청을 사용한 VUI B.1.1.28 P2 변이체의 중화Article Published on 2021-10-112022-09-11 Journal: Journal of Travel Medicine [Category] MERS, SARS, 변종, 진단, [키워드] B.1.1.28 B.1.1.28.2 Covaxin COVID-19 COVID-19 vaccine inactivated individual natural infection neutralization Neutralizing titer recipient reductions in SARS-CoV-2 sera shown Vaccine variant [DOI] 10.1093/jtm/taab077 PMC 바로가기 [Article Type] Article